These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25808703)

  • 41. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
    Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
    Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of vitamin D analog on bladder function and sensory signaling in animal models of cystitis.
    Shapiro B; Redman TL; Zvara P
    Urology; 2013 Feb; 81(2):466.e1-7. PubMed ID: 23374845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of bladder pain syndrome and interstitial cystitis: a systematic review.
    Pazin C; de Souza Mitidieri AM; Silva AP; Gurian MB; Poli-Neto OB; Rosa-E-Silva JC
    Int Urogynecol J; 2016 May; 27(5):697-708. PubMed ID: 26272202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of beta 2 agonists on smooth muscles of the bladder and on striated muscles of the urethra].
    Morita T; Kondo T; Takeyumi S; Dohoku S; Koshi A; Kawahara T; Kokura Y; Tsuchiya N; Nishimoto T; Tsuchida M
    Nihon Heikatsukin Gakkai Zasshi; 1989 Dec; 25(6):368-70. PubMed ID: 2577211
    [No Abstract]   [Full Text] [Related]  

  • 45. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of NMDAR reduces bladder hypertrophy and improves bladder function in cyclophosphamide induced cystitis.
    Liu M; Shen S; Kendig DM; Mahavadi S; Murthy KS; Grider JR; Qiao LY
    J Urol; 2015 May; 193(5):1676-83. PubMed ID: 25572034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
    Lai MC; Kuo YC; Kuo HC
    Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Experimental cystitis in rats and its chemotherapy].
    Konicková L; Prát V; Ritzerfeld W; Loew H
    Zentralbl Bakteriol Orig; 1970; 212(2):515-7. PubMed ID: 4910457
    [No Abstract]   [Full Text] [Related]  

  • 49. Intravesical 50% dimethyl sulfoxide (Rimso-50) in treatment of interstitial cystitis.
    Sant GR
    Urology; 1987 Apr; 29(4 Suppl):17-21. PubMed ID: 3551281
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cystitis treatment with immunoactive Escherichia coli fractions].
    Conrad S; Huland H
    Dtsch Med Wochenschr; 1997 Apr; 122(14):460. PubMed ID: 9138926
    [No Abstract]   [Full Text] [Related]  

  • 51. Antibiotic therapy-induced remission of bladder mucosa-associated lymphoid tissue (MALT) lymphoma carrying t(11;18)(q21;q21) apoptosis inhibitor 2-MALT1.
    Lucioni M; Nicola M; Riboni R; Croci GA; Rattotti S; Gotti M; Arcaini L; Paulli M; Cristina S; Valentini S; Martinengo C
    J Clin Oncol; 2013 Jul; 31(19):e304-6. PubMed ID: 23690413
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of chlorogenic acid on carbachol-induced contraction of mouse urinary bladder.
    Kaneda T; Sasaki N; Urakawa N; Shimizu K
    J Pharmacol Sci; 2018 Jan; 136(1):26-30. PubMed ID: 29277372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Possible pathophysiology of ketamine-related cystitis and associated treatment strategies.
    Jhang JF; Hsu YH; Kuo HC
    Int J Urol; 2015 Sep; 22(9):816-25. PubMed ID: 26087832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of sodium hyaluronate in the management of chemical and radiation cystitis.
    Sommariva ML; Sandri SD; Ceriani V
    Minerva Urol Nefrol; 2010 Jun; 62(2):145-50. PubMed ID: 20562794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The treatment of patients with interstitial cystitis, with special reference to intravesical DMSO.
    Stewart BH; Branson AC; Hewitt CB; Kiser WS; Straffon RA
    Trans Am Assoc Genitourin Surg; 1971; 63():69-74. PubMed ID: 5137793
    [No Abstract]   [Full Text] [Related]  

  • 56. Prophylactic role of oral L-arginine on histological and contractile changes in a rat chronic bladder injury model.
    Ozgür A; Onol FF; Ercan F; Tarcan T
    Urol Int; 2008; 81(3):347-52. PubMed ID: 18931556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical and urodynamic experience with intravesical hyaluronic acid in painful bladder syndrome associated with interstitial cystitis].
    Figueiredo AB; Palma P; Riccetto C; Herrmann V; Dambros M; Capmartin R
    Actas Urol Esp; 2011 Mar; 35(3):184-7. PubMed ID: 21397161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botulinum toxin type A may improve bladder function in a rat chemical cystitis model.
    Cayan S; Coşkun B; Bozlu M; Acar D; Akbay E; Ulusoy E
    Urol Res; 2003 Feb; 30(6):399-404. PubMed ID: 12599022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Long-term therapy of experimental E. coli cystitis with combination of sulfadiazine and nitrofurantoin].
    Prát V; Konícková L; Hatala M
    Cas Lek Cesk; 1971 Jun; 110(24):558-61. PubMed ID: 4932217
    [No Abstract]   [Full Text] [Related]  

  • 60. Protease-activated receptor-2-mediated contraction of urinary bladder is enhanced in cyclophosphamide-treated rats.
    Nakahara T; Kubota Y; Saito M; Sakamoto K; Ishii K
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):212-9. PubMed ID: 14673513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.